Tissue Regenix Group plc
Company Profile
Company website
Sector
Pharmaceuticals & Biotechnology (Biotechnology)
Description
Tissue Regenix Group plc (AIM: TRX) is a pioneering, international medical technology company focused on the development of regenerative products using two platform technologies, dCELL®, addressing soft tissue needs, and BioRinse™, providing inductive bone allografts.
.png "TRX - Hardman Co - Turning profitable and cash-generative (05.04.23)")
Investor Access
10
Sep
Event information
The Company will interim results for the six months ended 30 June will be announced on Tuesday 10 September 2024.
Investors can sign up to Investor Meet Company for free and add to meet Tissue Regenix via the following link: https://www.investormeetcompany.com/tissue-regenix-group-plc/register-investorVenue
Online
Time
Tuesday 10 September 2024 at 4:30pm
Financial Calendar
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results* | June |
| Interim Results* | 5 September |
| AGM* | June |
* Months based on previous announcements of this kind
